Endogenous antispermatogenic agents: prospects for male contraception.
D000728:Androgens / Q000502:physiology; D000818:Animals; D000988:Antispermatogenic Agents; D002352:Carrier Proteins / Q000502:physiology; D003613:Danazol / Q000502:physiology; D004967:Estrogens / Q000502:physiology; D005640:Follicle Stimulating Hormone / Q000502:physiology; D006131:Growth Inhibitors / Q000502:physiology; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000502:physiology; D007211:Indoles / Q000502:physiology; D007985:Leydig Cells / Q000502:physiology; D007986:Luteinizing Hormone / Q000502:physiology; D008297:Male; D010870:Pineal Gland / Q000502:physiology; D011372:Progestins / Q000502:physiology; D011956:Receptors, Cell Surface / Q000502:physiology; D012708:Sertoli Cells / Q000502:physiology; D013091:Spermatogenesis; D013737:Testis / Q000502:physiology
D000728:Androgens; D000988:Antispermatogenic Agents; D002352:Carrier Proteins; D004967:Estrogens; D006131:Growth Inhibitors; D007211:Indoles; D011372:Progestins; D011956:Receptors, Cell Surface; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D003613:Danazol